Lowering Risk in Pharma With Structured Content Authoring: What You Need to Know
To automate content development, pharmaceutical companies must move to structured content authoring.
To automate content development, pharmaceutical companies must move to structured content authoring.
In pharma, some digital marketing teams have embraced multi-channel publishing as a way to meet regulatory requirements.
Because labeling is global and requires localization, pharma companies gain even more benefit from content reuse.
Legacy tools and processes no longer support the business objectives for pharma. The only way to meet the growing demands for more content, faster, is to adopt a structured content ecosystem.
To be successful, we need to get everyone on board with a change. Learn how to persuade people who are totally against change, including what stance to take and how to avoid getting pulled in emotionally.
There is no such thing as a perfect structure because it is going to change over time. With new products and services should come new content types. And new content types often require new structures.